# FDA Warning Letter: K.C. Pharmaceuticals, Inc.
> 2026-08-18 · Center for Drug Evaluation and Research (CDER) · `b13f12a152b6af25`
## Letter
- **Company:** K.C. Pharmaceuticals, Inc.
- **Posted Date:** 2026-08-18
- **Letter Issue Date:** 2026-08-12
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · MORVS · CC0 1.0*